Analysis of Aβ-induced neurotoxicity and microglial responses in simple two- and three-dimensional human iPSC-derived

Mayuko Takata1, Kaneyasu Nishimura1, Koki Harada1

  • 1Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.

Tissue & Cell
|January 29, 2023
PubMed

Insights

Human-induced primitive macrophages (hiMacs) protect against Alzheimer's disease (AD) pathology in cell and organoid models. These hiMacs reduce neurodegeneration and alter amyloid-β plaque formation, offering new therapeutic avenues for AD.

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Alzheimer's Disease Research

Background:

  • Alzheimer's disease (AD) is characterized by amyloid-β (Aβ) plaques and neurodegeneration.
  • Microglia, brain-resident macrophages, are implicated in AD, but their precise role is unclear.
  • Existing cell and tissue culture models often fail to fully replicate the brain microenvironment for studying microglial function in AD.

Purpose of the Study:

  • To investigate the function and physiology of microglia in Alzheimer's disease using novel human-induced pluripotent stem cell (hiPSC)-derived models.
  • To evaluate the protective effects of hiPSC-induced primitive macrophages (hiMacs) on neuronal degeneration and Aβ pathology in vitro.

Main Methods:

  • Developed 2D cortical cell and 3D cortical organoid models using hiPSC-derived neurons and hiPSC-derived primitive macrophages (hiMacs).
  • Treated these models with aggregated Aβ₁-42 to induce AD-like pathology.
  • Analyzed hiMacs' phagocytosis of Aβ, their phenotypic changes (DAM-like), and their impact on neurodegeneration and plaque morphology.

Main Results:

  • Aβ₁-42 induced cortical neuron degeneration in both 2D and organoid cultures.
  • hiMacs effectively phagocytosed extracellular Aβ and adopted a disease-associated microglia (DAM)-like phenotype.
  • The presence of hiMacs attenuated neurodegeneration and promoted more circular, less clustered Aβ plaque formation in organoid models.

Conclusions:

  • hiPSC-derived cell and organoid systems supplemented with hiMacs are valuable tools for studying AD pathology and microglial roles.
  • hiMacs demonstrate a protective effect against Aβ-induced neurodegeneration.
  • These findings support the development of hiPSC-based models for discovering novel therapeutic strategies for Alzheimer's disease.

Related Concept Videos